137 related articles for article (PubMed ID: 1475358)
1. The combined use of 131I-labeled antibody and the hypoxic cytotoxin SR 4233 in vitro and in vivo.
Langmuir VK; Mendonca HL
Radiat Res; 1992 Dec; 132(3):351-8. PubMed ID: 1475358
[TBL] [Abstract][Full Text] [Related]
2. Local hyperthermia and SR 4233 enhance the antitumor effects of radioimmunotherapy in nude mice with human colonic adenocarcinoma xenografts.
Wilder RB; Langmuir VK; Mendonca HL; Goris ML; Knox SJ
Cancer Res; 1993 Jul; 53(13):3022-7. PubMed ID: 8319209
[TBL] [Abstract][Full Text] [Related]
3. Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin a-4 3-O-phosphate.
Pedley RB; Hill SA; Boxer GM; Flynn AA; Boden R; Watson R; Dearling J; Chaplin DJ; Begent RH
Cancer Res; 2001 Jun; 61(12):4716-22. PubMed ID: 11406542
[TBL] [Abstract][Full Text] [Related]
4. Potentiation by the hypoxic cytotoxin SR 4233 of cell killing produced by fractionated irradiation of mouse tumors.
Brown JM; Lemmon MJ
Cancer Res; 1990 Dec; 50(24):7745-9. PubMed ID: 2253217
[TBL] [Abstract][Full Text] [Related]
5. Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49.
Buchsbaum D; Khazaeli MB; Liu T; Bright S; Richardson K; Jones M; Meredith R
Cancer Res; 1995 Dec; 55(23 Suppl):5881s-5887s. PubMed ID: 7493364
[TBL] [Abstract][Full Text] [Related]
6. 131I-anticarcinoembryonic antigen therapy of LS174T human colon adenocarcinoma spheroids.
Langmuir VK; McGann JK; Buchegger F; Sutherland RM
Cancer Res; 1989 Jun; 49(12):3401-6. PubMed ID: 2720694
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: enhanced activity when combined with taxol chemotherapy.
Clarke K; Lee FT; Brechbiel MW; Smyth FE; Old LJ; Scott AM
Clin Cancer Res; 2000 Sep; 6(9):3621-8. PubMed ID: 10999754
[TBL] [Abstract][Full Text] [Related]
8. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
[TBL] [Abstract][Full Text] [Related]
9. Optimization of radioimmunotherapy using human malignant melanoma multicell spheroids as a model.
Kwok CS; Crivici A; MacGregor WD; Unger MW
Cancer Res; 1989 Jun; 49(12):3276-81. PubMed ID: 2720681
[TBL] [Abstract][Full Text] [Related]
10. Combining radioimmunotherapy with antihypoxia therapy 2-deoxy-D-glucose results in reduction of therapeutic efficacy.
Dearling JL; Qureshi U; Begent RH; Pedley RB
Clin Cancer Res; 2007 Mar; 13(6):1903-10. PubMed ID: 17363547
[TBL] [Abstract][Full Text] [Related]
11. Combined radioimmunotherapy and radiotherapy of human colon carcinoma grafted in nude mice.
Buchegger F; Rojas A; Delaloye AB; Vogel CA; Mirimanoff RO; Coucke P; Sun LQ; Raimondi S; Denekamp J; Pèlgrin A
Cancer Res; 1995 Jan; 55(1):83-9. PubMed ID: 7805046
[TBL] [Abstract][Full Text] [Related]
12. The hypoxic cytotoxin SR 4233 increases the effectiveness of radioimmunotherapy in mice with human non-Hodgkin's lymphoma xenografts.
Wilder RB; McGann JK; Sutherland WR; Waller EK; Minchinton AI; Goris ML; Knox SJ
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):119-26. PubMed ID: 8270432
[TBL] [Abstract][Full Text] [Related]
13. Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with 131I-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody.
Gautherot E; Kraeber-Bodéré F; Daniel L; Fiche M; Rouvier E; Saï-Maurel C; Thedrez P; Chatal JF; Barbet J
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3177s-3182s. PubMed ID: 10541361
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antitumor activity of combination radioimmunotherapy (131I-labeled monoclonal antibody A33) with chemotherapy (fluorouracil).
Tschmelitsch J; Barendswaard E; Williams C; Yao TJ; Cohen AM; Old LJ; Welt S
Cancer Res; 1997 Jun; 57(11):2181-6. PubMed ID: 9187118
[TBL] [Abstract][Full Text] [Related]
15. The radiation response of a human colon adenocarcinoma grown in monolayer, as spheroids, and in nude mice.
West CM; Sutherland RM
Radiat Res; 1987 Oct; 112(1):105-15. PubMed ID: 3659291
[TBL] [Abstract][Full Text] [Related]
16. Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and 131I-labeled bivalent hapten.
Gautherot E; Rouvier E; Daniel L; Loucif E; Bouhou J; Manetti C; Martin M; Le Doussal JM; Barbet J
J Nucl Med; 2000 Mar; 41(3):480-7. PubMed ID: 10716323
[TBL] [Abstract][Full Text] [Related]
17. Combined radioimmunotherapy and chemotherapy of human colon carcinoma grafted in nude mice, advantages and limitations.
Chalandon Y; Mach JP; Pèlegrin A; Folli S; Buchegger F
Anticancer Res; 1992; 12(4):1131-9. PubMed ID: 1503403
[TBL] [Abstract][Full Text] [Related]
18. Radioimmunotherapy of human colon cancer xenografts by using 131I labeled-CAb1 F(ab')2.
Li L; Xu HY; Mi L; Bian HJ; Qin J; Xiong H; Feng Q; Wen N; Tian R; Xu LQ; Shen XM; Tang H; Chen ZN
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1238-44. PubMed ID: 16979831
[TBL] [Abstract][Full Text] [Related]
19. Reconciliation of tumor dose response to external beam radiotherapy versus radioimmunotherapy with 131iodine-labeled antibody for a colon cancer model.
Roberson PL; Buchsbaum DJ
Cancer Res; 1995 Dec; 55(23 Suppl):5811s-5816s. PubMed ID: 7493351
[TBL] [Abstract][Full Text] [Related]
20. Comparison of equitoxic radioimmunotherapy and chemotherapy in the treatment of human colonic cancer xenografts.
Blumenthal RD; Sharkey RM; Natale AM; Kashi R; Wong G; Goldenberg DM
Cancer Res; 1994 Jan; 54(1):142-51. PubMed ID: 8261435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
